Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

10832	Companies
235110	Keywords
164011	Articles
125893	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 09/05/2024 at 14:00, 1 year 11 months ago

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1
Moderna's updated COVID-19 mRNA vaccine targeting SARS-CoV-2 variant JN.1 receives positive opinion from CHMP for European Commission authorization decision for 2024-2025 vaccination season

COVID-19 Vaccine European Commission Moderna MRNA Spikevax
BRIEF

published on 09/03/2024 at 14:35, 1 year 11 months ago

Moderna Receives MHRA Authorization for Updated COVID-19 Vaccine Targeting JN.1 Variant

COVID-19 Moderna Vaccine JN.1 Variant MHRA
BRIEF

published on 09/03/2024 at 14:35, 1 year 11 months ago

Moderna reçoit l'autorisation de la MHRA pour un vaccin COVID-19 mis à jour ciblant la variante JN.1

Moderne COVID 19 Vaccin Variante JN.1 MHRA
PRESS RELEASE

published on 09/03/2024 at 14:30, 1 year 11 months ago

Moderna Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1
MHRA authorizes Moderna's updated COVID-19 vaccine targeting JN.1 variant. Available for NHS and private purchase in the UK. Follows WHO recommendation for JN.1 subvariants

COVID-19 Vaccine Moderna JN.1 Variant MHRA Authorization Private Purchase
BRIEF

published on 09/02/2024 at 13:05, 1 year 11 months ago

Taiwan FDA Approves Moderna’s COVID-19 Vaccine Targeting SARS-CoV-2 Variant JN.1

COVID-19 Vaccine Moderna Spikevax Taiwan FDA SARS-CoV-2 JN.1
BRIEF

published on 09/02/2024 at 13:05, 1 year 11 months ago

La FDA de Taïwan approuve le vaccin COVID-19 de Moderna ciblant la variante JN.1 du SRAS-CoV-2

Moderne Vaccin Contre Le Covid-19 Spikevax SARS-CoV-2 JN.1 FDA De Taïwan
PRESS RELEASE

published on 09/02/2024 at 13:00, 1 year 11 months ago

Taiwan Food & Drug Administration Approves Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1
Moderna receives approval for updated COVID-19 vaccine formulation targeting SARS-CoV-2 variant JN.1 from Taiwan FDA. Regulatory decisions globally expected soon

COVID-19 Vaccine Moderna Spikevax SARS-CoV-2 Variant Taiwan FDA
BRIEF

published on 08/29/2024 at 14:05, 1 year 11 months ago

Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination

COVID-19 Moderna Vaccination Health Campaign Public Awareness
BRIEF

published on 08/29/2024 at 14:05, 1 year 11 months ago

Moderna lance une campagne nationale de sensibilisation pour favoriser la vaccination contre la COVID-19

Moderne COVID 19 Vaccination Campagne De Santé Sensibilisation Du Public
PRESS RELEASE

published on 08/29/2024 at 14:00, 1 year 11 months ago

Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination
Moderna launches 'Do It For You & Them' campaign to drive vaccination rates in the U.S. and inform about COVID-19 risks & impact, updated vaccines available for KP.2 variant

COVID-19 Moderna Awareness Campaign KP.2 Variant Vaccination Rates

Accesswire

Published on 08/13/2026 at 22:38, 34 minutes ago

Predictiv AI Announces Debt Settlement and Provides Additional Details of Previously Announced Consulting Agreement With Aktien Media Inc.
Published on 08/13/2026 at 19:55, 3 hours 17 minutes ago

NuRAN Wireless Receives Nasdaq Approval to List on The Nasdaq Capital Market; Trading Expected to Commence August 17, 2026 and C$7.6 Million Financing to Close August 14, 2026
Published on 08/13/2026 at 17:55, 5 hours 17 minutes ago

Alset AI Announces Agreement to Sell 9.9% Interest in Lyken AI Computing to FingerMotion
Published on 08/13/2026 at 14:31, 8 hours 41 minutes ago

Wi2Wi Announces Strategic Equipment Investments to Expand Production Capacity
Published on 08/13/2026 at 14:15, 8 hours 57 minutes ago

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th

View all ACCESSWIRE

EQS Group

Published on 08/13/2026 at 22:56, 16 minutes ago

BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING AND CONCURRENT SHARE REPURCHASE
Published on 08/13/2026 at 18:17, 4 hours 55 minutes ago

EQS-Adhoc: Energiekontor AG: Energiekontor adjusts earnings guidance for the 2026 financial year
Published on 08/13/2026 at 18:00, 5 hours 12 minutes ago

Issue of Equity
Published on 08/13/2026 at 18:00, 5 hours 12 minutes ago

Deutsche EuroShop reports good operational performance in the first half of 2026 and confirms its forecast
Published on 08/13/2026 at 17:50, 5 hours 22 minutes ago

EQS-Adhoc: NFON AG updates guidance for the 2026 financial year

Les Echos

Published on 08/13/2026 at 18:00, 5 hours 12 minutes ago

Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 2 days 5 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 2 days 5 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 3 days 5 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 3 days 5 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

View all LES ECHOS COMFI WIRE